These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38228381)

  • 1. Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5-6 years.
    Tréluyer L; Zana-Taieb E; Jarreau PH; Benhammou V; Kuhn P; Letouzey M; Marchand-Martin L; Onland W; Pierrat V; Saade L; Ancel PY; Torchin H
    Arch Dis Child Fetal Neonatal Ed; 2024 Jun; 109(4):443-449. PubMed ID: 38228381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodevelopment and healthcare utilisation at age 5-6 years in bronchopulmonary dysplasia: an EPIPAGE-2 cohort study.
    Tréluyer L; Nuytten A; Guellec I; Jarreau PH; Benhammou V; Cambonie G; Truffert P; Marchand-Martin L; Ancel PY; Torchin H
    Arch Dis Child Fetal Neonatal Ed; 2023 Dec; 109(1):26-33. PubMed ID: 37364896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study.
    Pierrat V; Marchand-Martin L; Marret S; Arnaud C; Benhammou V; Cambonie G; Debillon T; Dufourg MN; Gire C; Goffinet F; Kaminski M; Lapillonne A; Morgan AS; Rozé JC; Twilhaar S; Charles MA; Ancel PY;
    BMJ; 2021 Apr; 373():n741. PubMed ID: 33910920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.
    Pierrat V; Marchand-Martin L; Arnaud C; Kaminski M; Resche-Rigon M; Lebeaux C; Bodeau-Livinec F; Morgan AS; Goffinet F; Marret S; Ancel PY;
    BMJ; 2017 Aug; 358():j3448. PubMed ID: 28814566
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
    Ten Hove CH; Vliegenthart RJ; Te Pas AB; Brouwer E; Rijken M; van Wassenaer-Leemhuis AG; van Kaam AH; Onland W
    Neonatology; 2016; 110(1):21-6. PubMed ID: 26967910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocolysis after preterm prelabor rupture of membranes and 5-year outcomes: a population-based cohort study.
    Lorthe E; Marchand-Martin L; Letouzey M; Aubert AM; Pierrat V; Benhammou V; Delorme P; Marret S; Ancel PY; Goffinet F; L'Hélias LF; Kayem G;
    Am J Obstet Gynecol; 2024 May; 230(5):570.e1-570.e18. PubMed ID: 37827270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term neurological and neurodevelopmental outcome of neonatal listeriosis in France: a prospective, matched, observational cohort study.
    Charlier C; Barrault Z; Rousseau J; Kermorvant-Duchemin E; Meyzer C; Semeraro M; Fall M; Coulpier G; Leclercq A; Charles MA; Ancel PY; Lecuit M
    Lancet Child Adolesc Health; 2023 Dec; 7(12):875-885. PubMed ID: 37871603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
    Lorthe E; Torchin H; Delorme P; Ancel PY; Marchand-Martin L; Foix-L'Hélias L; Benhammou V; Gire C; d'Ercole C; Winer N; Sentilhes L; Subtil D; Goffinet F; Kayem G
    Am J Obstet Gynecol; 2018 Sep; 219(3):298.e1-298.e14. PubMed ID: 29852153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5-year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort study.
    Foix-L'Hélias L; Marret S; Ancel PY; Marchand L; Arnaud C; Fresson J; Picaud JC; Rozé JC; Theret B; Burguet A; Larroque B; Kaminski M;
    BJOG; 2008 Jan; 115(2):275-82. PubMed ID: 18081606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study.
    Larroque B; Ancel PY; Marret S; Marchand L; André M; Arnaud C; Pierrat V; Rozé JC; Messer J; Thiriez G; Burguet A; Picaud JC; Bréart G; Kaminski M;
    Lancet; 2008 Mar; 371(9615):813-20. PubMed ID: 18328928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
    Vliegenthart RJ; Ten Hove CH; Onland W; van Kaam AH
    Neonatology; 2017; 111(2):162-171. PubMed ID: 27760427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopment at age 5.5 years according to Ages & Stages Questionnaire at 2 years' corrected age in children born preterm: the EPIPAGE-2 cohort study.
    Charkaluk ML; Kana GD; Benhammou V; Guellec I; Letouzey M; Morgan AS; Nuytten A; Torchin H; Twilhaar S; Cambonie G; Marret S; Ancel PY; Pierrat V;
    Arch Dis Child Fetal Neonatal Ed; 2024 Aug; 109(5):519-526. PubMed ID: 38290830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea.
    Sreenan C; Etches PC; Demianczuk N; Robertson CM
    J Pediatr; 2001 Dec; 139(6):832-7. PubMed ID: 11743509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic apnoea of prematurity treated with doxapram and aminophylline.
    Sagi E; Eyal F; Alpan G; Patz D; Arad I
    Arch Dis Child; 1984 Mar; 59(3):281-3. PubMed ID: 6424586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraventricular Hemorrhage in Very Preterm Children: Mortality and Neurodevelopment at Age 5.
    Tréluyer L; Chevallier M; Jarreau PH; Baud O; Benhammou V; Gire C; Marchand-Martin L; Marret S; Pierrat V; Ancel PY; Torchin H
    Pediatrics; 2023 Apr; 151(4):. PubMed ID: 36919442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
    Roychoudhury S; Lodha A; Synnes A; Abou Mehrem A; Canning R; Banihani R; Beltempo M; Theriault K; Yang J; Shah PS; Soraisham AS; ; ;
    Am J Obstet Gynecol; 2021 Sep; 225(3):276.e1-276.e9. PubMed ID: 33798481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study.
    Eyal F; Alpan G; Sagi E; Glick B; Peleg O; Dgani Y; Arad I
    Pediatrics; 1985 Apr; 75(4):709-13. PubMed ID: 3982903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective study shows that doxapram therapy avoided the need for endotracheal intubation in most premature neonates.
    Flint R; Halbmeijer N; Meesters N; van Rosmalen J; Reiss I; van Dijk M; Simons S
    Acta Paediatr; 2017 May; 106(5):733-739. PubMed ID: 28130789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxapram treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2001; (4):CD000074. PubMed ID: 11687067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxapram treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2000; (2):CD000074. PubMed ID: 10796114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.